Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Taysha Gene Therapies Inc (TSHA)

Taysha Gene Therapies Inc (TSHA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Taysha Gene Therapies Reports Third Quarter 2024 Financial Results and Provides Corporate Update

TSHA : 2.27 (+2.71%)
Taysha Gene Therapies to Release Third Quarter 2024 Financial Results and Host Conference Call and Webcast On November 13

TSHA : 2.27 (+2.71%)
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

TSHA : 2.27 (+2.71%)
Taysha Gene Therapies to Present Biodistribution Data from an Analysis Evaluating AAV9 Gene Therapy Delivery at the Upcoming 31st Annual ESGCT Congress

TSHA : 2.27 (+2.71%)
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

TSHA : 2.27 (+2.71%)
3 Growth Stocks That Could Go Parabolic in 2024

These innovation-oriented companies could take flight this year.

ABCL : 2.76 (-5.48%)
CERS : 1.8000 (-3.23%)
TSHA : 2.27 (+2.71%)
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating Taysha Gene Therapies, Inc. (NASDAQ: TSHA) for Potential Breaches of Fiduciary Duty By Its Board of Directors

/PRNewswire/ -- Purcell & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of...

TSHA : 2.27 (+2.71%)
2 Healthcare Stocks That More Than Tripled Recently. Can They Keep Climbing?

These highly volatile stocks recently rocketed higher, but what are the chances that they'll be able to provide further gains?

CGC : 3.74 (-5.08%)
TSHA : 2.27 (+2.71%)
S&P Futures Tick Lower As Investors Await Fed Rate Decision, Snap Plunges on Weak Outlook

March S&P 500 futures (ESH23) are trending down -0.41% this morning after three major U.S. benchmark indices finished the regular session higher as market participants weighed up economic data and a slew...

ESH23 : 3,957.05s (-0.09%)
GM : 57.62 (-0.16%)
PHM : 129.44 (+1.54%)
SNAP : 10.76 (-3.15%)
HUSQB.S.DX : 64.820 (+1.19%)
WDC : 63.22 (+0.78%)
EA : 164.12 (+0.86%)
AMD : 138.84 (-0.33%)
JSPR : 22.10 (-3.07%)
TSHA : 2.27 (+2.71%)
Taysha Gene Therapies (NASDAQ: TSHA) Receives $50 Million Strategic Investment From Astellas Pharma to Develop AAV-Based Gene Therapeutics

Taysha Gene Therapies, Inc. (NASDAQ: TSHA) is a biotechnology company that is focused on developing gene therapies to treat monogenic

TSHA : 2.27 (+2.71%)

Barchart Exclusives

2 Energy Dividend Stocks to Buy This November for Growth and Income
For investors seeking steady gains, these two dividend-paying energy stocks could be smart picks. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar